Continue to site >
Trending ETFs
Guide

/

Health Care

/

Medical Equipment & Devices

/

Health Care Supplies

Health Care Supplies Dividends Stocks, ETFs, Funds

As of 03/23/2023. Within the healthcare sector, medical equipment and device manufacturers... As of 03/23/2023. Within the healthcare sector, medical equipment and device manufacturers are major suppliers to hospitals and healthcare facilities. Companies in this industry manufacture and supply pharmaceuticals, medical tools, endoscopes, cameras, video sets, clinical testing systems and other products used by healthcare professionals. View more View less

As of 03/23/2023. Within the healthcare sector, medical equipment and device manufacturers are major suppliers to hospitals and healthcare facilities. Companies in this industry manufacture and supply pharmaceuticals, medical tools, endoscopes, cameras, video... As of 03/23/2023. Within the healthcare sector, medical equipment and device manufacturers are major suppliers to hospitals and healthcare facilities. Companies in this industry manufacture and supply pharmaceuticals, medical tools, endoscopes, cameras, video sets, clinical testing systems and other products used by healthcare professionals. View more View less

Overview

Payout

Div Growth

Returns

Ratings

Allocations

Fees

About

Resmed Inc.Resmed

RMD | Stock | Common

$210.78

-1.44%

$30.95 B

0.83%

$1.76

5/11

2023

$0.44

Last $0.44

Estimated

2.76%

-

$328.94

-1.82%

$24.65 B

0.23%

$0.76

4/25

2023

$0.19

Last $0.19

Declared

42.35%

-

$39.16

-1.14%

$19.27 B

2.96%

$1.16

2/23

2023

$0.29

Last $0.29

Declared

-22.29%

-

Teleflex IncorporatedTeleflex

TFX | Stock | Common

$240.80

-1.66%

$11.14 B

0.56%

$1.36

5/12

2023

$0.34

Last $0.34

Estimated

-1.91%

-

Conmed Corp.Conmed

CNMD | Stock | Common

$96.84

+2.61%

$2.85 B

0.83%

$0.80

3/14

2023

$0.20

Last $0.20

Declared

6.48%

-

$90.61

-3.44%

$338.64 M

1.30%

$1.18

3/16

2023

$0.30

Last $0.30

Declared

-6.65%

-

Get dividend stock picks, research and news in your inbox each week.

Our research team runs the industry’s toughest dividend screening test and only picks from the top 5%.